Notably, glioblastoma cells resistant to TMZ chemotherapy exhibited significantly higher levels of these amyloid oligomers of mutated TP53 compared to glioblastoma cells with wild-type TP53 or hotspot TP53 mutations not associated with chemoresistance (44). Here, TP53 is linked to glioblastoma.